Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$25.1K Buy
136
+1
+0.7% +$231 ﹤0.01% 1262
2024
Q4
$26.6K Buy
135
+13
+11% +$2.5K ﹤0.01% 1124
2024
Q3
$25.4K Sell
122
-1
-0.8% -$213 ﹤0.01% 1162
2024
Q2
$28.8K Sell
123
-9
-7% -$1.78K ﹤0.01% 1041
2024
Q1
$23.4K Buy
132
+19
+17% +$3K ﹤0.01% 1132
2023
Q4
$15.5K Buy
113
+11
+11% +$1.27K ﹤0.01% 1321
2023
Q3
$11.5K Hold
102
﹤0.01% 1339
2023
Q2
$12K Buy
102
+7
+7% +$716 ﹤0.01% 1356
2023
Q1
$9.93K Buy
95
+5
+6% +$468 ﹤0.01% 1459
2022
Q4
$7.35K Buy
90
+41
+84% +$3.35K ﹤0.01% 1591
2022
Q3
$4K Sell
49
-1
-2% -$98 ﹤0.01% 1778
2022
Q2
$4K Buy
50
+4
+9% +$398 ﹤0.01% 1667
2022
Q1
$5K Hold
46
﹤0.01% 1597
2021
Q4
$7K Hold
46
﹤0.01% 1405
2021
Q3
$5K Buy
46
+5
+12% +$496 ﹤0.01% 1250
2021
Q2
$4K Buy
41
+9
+28% +$867 ﹤0.01% 1377
2021
Q1
$3K Buy
+32
New +$2.58K ﹤0.01% 1442

Other funds holding NVMI

Lindbrook Capital's NVMI Position: Q1 2025 in Review

Lindbrook Capital increased its Nova (NVMI) stake by 0.74% in Q1 2025, buying an estimated $231 and bringing the position to 136 shares worth $25.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1262.

Lindbrook Capital first reported a position in NVMI in Q1 2021 and has held it in 17 quarters since. The position peaked at $28.8K in Q2 2024. 250 funds tracked by Wall St. Rank hold NVMI as of Q1 2025.

  • Lindbrook Capital held 136 shares of Nova worth $25.1K as of Q1 2025.
  • Lindbrook Capital bought 1 Nova share in Q1 2025, an estimated $231.
  • Nova made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1262 holding.
  • Lindbrook Capital first reported a position in Nova in Q1 2021 and has held it in 17 quarters since.
  • Lindbrook Capital's Nova position peaked at $28.8K in Q2 2024.
  • 250 funds tracked by Wall St. Rank held Nova as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.